Detalhe da pesquisa
1.
Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial.
Blood
; 135(2): 97-107, 2020 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31738834
2.
Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting.
J Transl Med
; 13: 214, 2015 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26143264
3.
Mechanisms regulating PD-L1 expression on tumor and immune cells.
J Immunother Cancer
; 7(1): 305, 2019 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31730010
4.
The Intratumoral Balance between Metabolic and Immunologic Gene Expression Is Associated with Anti-PD-1 Response in Patients with Renal Cell Carcinoma.
Cancer Immunol Res
; 4(9): 726-33, 2016 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27491898
5.
Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade.
Clin Cancer Res
; 21(17): 3969-76, 2015 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25944800
6.
Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade.
J Immunother Cancer
; 2(1): 42, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25516806